Literature DB >> 207383

Specific immunity to human papilloma virus (HPV) in patients with genital warts.

J Viac, M J Staquet, M Miguet, M Chabanon, J Thivolet.   

Abstract

A study of human papilloma virus (HPV) specific cellular and humoral immunity in 30 patients with genital warts is reported. By in vivo testing with purified, inactivated plantar wart virus, a cell-mediated immunity to HPV was determined in 60% of patients. Circulating antibodies, evaluated by immunofluorescence testing, were rare, but these increased after an intradermal test had been carried out, especially in patients with a positive skin test, suggesting a booster effect. No significant difference was found between this group of patients and those having skin warts. Our results showed a specific immune response to HPV in most patients, confirming the role of the viral agent in the induction of genital warts.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 207383      PMCID： PMC1045484          DOI： 10.1136/sti.54.3.172

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN： 0007-134X


  13 in total

1.  Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens.

Authors:  A K Lee; M Eisinger
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

2.  Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus.

Authors:  J Viac; J Thivolet; Y Chardonnet
Journal:  Br J Dermatol       Date:  1977-10       Impact factor: 9.302

3.  Wart-associated antigens. I. Isolation of tissue antigens using antibody immunoadsorbents.

Authors:  F Pass; D M Marcus
Journal:  J Invest Dermatol       Date:  1973-05       Impact factor: 8.551

4.  Demonstration of virus particles in human genital warts.

Authors:  J D Oriel; J D Almeida
Journal:  Br J Vener Dis       Date:  1970-02

5.  Wart-virus antibodies and the prognosis of wart disease.

Authors:  S Pyrhönen; K Penttinen
Journal:  Lancet       Date:  1972-12-23       Impact factor: 79.321

6.  Localization of wart virus antigen in human plantar warts (verrucae vulgares).

Authors:  J Genner
Journal:  Acta Derm Venereol       Date:  1971       Impact factor: 4.437

7.  Intranuclear virus particles in human genital wart tissue: observations on the ultrastructure of the epidermal layer.

Authors:  A E Dun; M M Ogilvie
Journal:  J Ultrastruct Res       Date:  1968-02

8.  Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma virus (HPV).

Authors:  J Viac; J Thivolet; M R Hegazy; Y Chardonnet; C Dambuyant
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

9.  Serological studies with human papova (wart) virus.

Authors:  M M Ogilvie
Journal:  J Hyg (Lond)       Date:  1970-09

10.  An in vivo study of cell-mediated immunity in human warts. Preliminary results.

Authors:  J Thivolet; M R Hegazy; J Viac; Y Chardonnet
Journal:  Acta Derm Venereol       Date:  1977       Impact factor: 4.437
View more
  3 in total

1.  Immunophenotypes of lymphocytes in prospectively followed up human papillomavirus lesions of the cervix.

Authors:  M Väyrynen; K Syrjänen; R Mäntyjärvi; O Castrén; S Saarikoski
Journal:  Genitourin Med       Date:  1985-06

2.  Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.

Authors:  A Wikström; C Eklund; G Von Krogh; P Lidbrink; J Dillner
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

3.  The relation between the type of immunoreactive cells found in human papillomavirus (HPV) lesions of the uterine cervix and the subsequent behaviour of these lesions.

Authors:  K Syrjänen; M Väyrynen; O Castrén; R Mäntyjärvi; M Yliskoski
Journal:  Arch Gynecol       Date:  1984
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.